Wharton's Jelly MSCs: Potential Weapon to Sharpen for Our Battle against DM
© 2020 Elsevier Ltd Diabetes mellitus (DM) is a devastating metabolic disease. Stem cell therapy provides great hope to all diabetic patients. Umbilical cord (UC) Wharton's jelly mesenchymal stem cells (WJ-MSCs) specifically provides a potential cell therapy for DM. In this article, we discuss major advantages of WJ-MSCs and challenges facing their clinical utility in DM.
Kassem, Dina H. and Kamal, Mohamed M., "Wharton's Jelly MSCs: Potential Weapon to Sharpen for Our Battle against DM" (2020). Pharmacy. 309.